Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 202743
Company: PADAGIS ISRAEL
Company: PADAGIS ISRAEL
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | 0.2055MG/SPRAY | SPRAY, METERED;NASAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 05/08/2014 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 11/13/2020 | SUPPL-8 | Labeling-Package Insert |
Label is not available on this site. |
||
| 11/13/2020 | SUPPL-3 | Labeling-Package Insert |
Label is not available on this site. |